Skip to main content

Paula Fernández Álvarez

Institutions of which they are part

Research technician
Genetics Medicine
Vall Hebron Institut de Recerca

Paula Fernández Álvarez

Institutions of which they are part

Research technician
Genetics Medicine
Vall Hebron Institut de Recerca

Projects

Validación funcional de variantes en el genoma mitocondrial y nuclear en pacientes con patologia mitocondrial

IP: Elena García Arumí
Collaborators: Mª Jesus Melia Grimal, Clara Carnicer Cáceres, Paula Fernández Álvarez
Funding agency: Instituto de Salud Carlos III
Funding: 102850
Reference: PI19/01772
Duration: 01/01/2020 - 31/12/2023

Estudios funcionales de mutaciones del gen CFTR para establecer una terapia personalizada en pacientes con Fibrosis Quística

IP: Estudios funcionales de mutaciones del gen CFTR para establecer una terapia personalizada en pacientes con Fibrosis Quística
Collaborators: Paula Fernández Álvarez, Silvia Gartner Tizzano
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 104213
Reference: MM/XIV/RECERCA/2017/TIZZANO
Duration: 10/10/2017 - 30/09/2021

Abordaje genético-molecular de enfermedades mitocondriales del sistema OXPHOS: identificación de factores condicionantes del fenotipo.

IP: Elena García Arumí
Collaborators: Albert Blanco Grau, Mª Jesus Melia Grimal, Paula Fernández Álvarez
Funding agency: Instituto de Salud Carlos III
Funding: 212052.5
Reference: PI15/01428
Duration: 01/01/2016 - 30/06/2019

Biomarcadores diagnósticos y pronósticos de recidiva de glomerulonefritis segmentaria y focal en trasplante de riñón

IP: Joan López Hellin
Collaborators: Biomarcadores diagnósticos y pronósticos de recidiva de glomerulonefritis segmentaria y focal en trasplante de riñón, Daniel Serón Micas, Paula Fernández Álvarez
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 20000
Reference: FMM-2011-08
Duration: 28/07/2011 - 27/07/2012

Related news

Over the course of one week, it will host in-person assessments for 35 families to better understand the progression of the disease and contribute to the development of new therapies.

The results show that, in some patients with mutations in the X chromosome, the healthy gene is inactivated and the mutated gene manifests itself, which favors the onset of the disease.

On January 24, a session was held to explain what these three-dimensional models are and what advantages they have, as well as to review some of their applications in research.

Related professionals

Alba Mir Cros

Alba Mir Cros

Postdoctoral researcher
Microbiology
Read more
Vicenta Pujol Blaya

Vicenta Pujol Blaya

Predoctoral researcher
Physical Medicine and Rehabilitation
Read more
Sabina Salicrú Riera

Sabina Salicrú Riera

Predoctoral researcher
Biomedical Research in Gynaecology
Read more
Nuria  Roson  Gradaille

Nuria Roson Gradaille

Research technician
Molecular Imaging and Therapy
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.